+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032- Product Image
Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032- Product Image
Sale

Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6078287
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Contraceptive Drug Eluting Devices Market is projected to reach USD 700.89 Million in 2026. It is expected to continue growing at a CAGR of 10.33%, reaching USD 1.27 Billion by 2032.

Contraceptive Drug-Eluting Devices: Executive Overview

Contraceptive drug-eluting devices combine a physical contraceptive method with controlled release of an active pharmaceutical ingredient. The category includes intrauterine systems and related delivery technologies intended to provide sustained local or systemic contraceptive effects. Its development is shaped by clinical performance, duration of use, reversibility, safety, regulatory requirements, manufacturing quality, provider training, and user preference. Access also depends on health-system capacity, affordability, informed choice, and reliable counseling.

Long-Acting, Reversible, and User-Centered Care Are Reshaping Adoption

The landscape is shifting toward long-acting, reversible contraception that reduces reliance on daily adherence while preserving the option of discontinuation. Product design is increasingly evaluated through a broader lens that includes insertion experience, bleeding-pattern counseling, ease of removal, anatomical fit, duration, tolerability, and compatibility with different stages of reproductive life. Procurement and service-delivery decisions are also placing greater emphasis on continuity of supply, post-market surveillance, equitable access, and informed consent rather than product availability alone.

Artificial Intelligence Strengthens Evidence Generation and Service Delivery

Artificial intelligence can support this field by identifying safety signals in longitudinal records, improving demand and inventory planning, assisting image and procedure documentation, and personalizing educational content. It may also help researchers analyze discontinuation patterns and identify populations needing additional counseling. These benefits depend on representative data, clinical validation, privacy safeguards, transparent governance, and human oversight. AI should augment-not replace-licensed clinicians and shared decision-making, particularly where eligibility, adverse effects, or removal require individualized assessment.

Regional Insights: Access Models and Health-System Capacity Differ

North America is characterized by advanced clinical infrastructure, varied insurance coverage, and strong attention to patient autonomy, safety monitoring, and reproductive-health access. Latin America continues to reflect the importance of public-sector procurement, provider training, and reducing geographic and socioeconomic barriers. Europe generally benefits from established contraceptive guidance and regulatory systems, while access and reimbursement remain country-specific. The Middle East shows diverse patterns shaped by national health policies, cultural context, and counseling needs. Africa’s priorities include affordable procurement, task-sharing, supply reliability, and integration with broader sexual and reproductive-health services. Asia-Pacific spans highly developed and rapidly expanding health systems, with major opportunities linked to urban-rural access, provider capacity, and culturally responsive education.

Group Insights: Policy Blocs Influence Procurement and Standards

ASEAN members present varied regulatory environments and health-system resources, making regional coordination, supply resilience, and provider education important. BRICS economies encompass substantial differences in manufacturing capability, public procurement, reimbursement, and access, creating a need for locally relevant implementation strategies. The European Union benefits from regulatory coordination while national reimbursement and service delivery remain decisive. G7 countries tend to emphasize evidence quality, safety surveillance, patient-centered care, and mature clinical infrastructure. GCC countries combine strong investment capacity with differing population structures, expatriate-health needs, and access pathways. NATO members span diverse health systems, so the grouping is most relevant to resilience, emergency preparedness, and continuity of essential reproductive-health services rather than a uniform demand pattern.

Country Insights: National Policy and Care Pathways Remain Decisive

Australia and Canada have established health systems where reimbursement, primary-care integration, and geographic access influence use. Brazil and Mexico face the parallel priorities of public-sector reach, regional disparities, and consistent counseling. China and India combine large and diverse populations with substantial differences between urban and rural services, making scalable training and reliable distribution important. Japan and South Korea place emphasis on clinical quality, informed choice, and demographic and health-policy context. France, Germany, Italy, and Spain operate within European regulatory frameworks but differ in reimbursement, prescribing, and provider pathways. The United Kingdom’s publicly organized services make commissioning, access equity, and continuity of care central. The United States reflects significant variation by state, payer, provider availability, and reproductive-health policy. Russia’s environment is shaped by national regulation, healthcare access differences, and the availability of qualified counseling and follow-up.

Recommendations for Leaders: Build Trust, Access, and Resilience

Industry leaders should prioritize evidence that reflects real-world users, including adolescents where ethically appropriate, postpartum patients, people with differing anatomies, and populations underserved by current services. Product and service strategies should pair safety and effectiveness data with transparent counseling on expected bleeding changes, contraindications, insertion, removal, and follow-up. Organizations should strengthen manufacturing quality, dual-source critical inputs, temperature and logistics controls where relevant, and post-market surveillance. Partnerships with public health systems can improve provider training and equitable distribution, while digital tools should be governed for privacy, bias control, accessibility, and clinical accountability. Success should be measured through informed uptake, continuation, satisfaction, complication management, and access equity-not volume alone.

Research Methodology: Evidence Synthesis Without Unsupported Market Claims

This executive summary uses the defined market scope of contraceptive drug-eluting devices and organizes findings across technology, clinical practice, regulation, health-system delivery, access, and regional context. Insights should be validated against peer-reviewed clinical literature, regulatory and safety communications, public-health guidance, procurement documentation, national reimbursement policies, and manufacturer-independent post-market evidence. Geographic comparisons are qualitative because countries and groupings differ in definitions, reporting systems, eligibility criteria, and care pathways. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Sustainable Progress Requires More Than Device Innovation

Contraceptive drug-eluting devices can contribute to broader contraceptive choice when clinical evidence, informed consent, provider capability, affordability, and dependable follow-up are addressed together. The strongest strategies will adapt to local policy and health-system conditions while maintaining rigorous safety monitoring and respect for user preferences. Responsible use of artificial intelligence, resilient supply chains, and equity-focused implementation can reinforce-not substitute for-high-quality human care. Long-term progress will depend on making appropriate options understandable, available, and removable for the people who choose them.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Contraceptive Drug Eluting Devices Market, by Product Type
7.1. Introduction
7.2. Implant
7.3. Intrauterine System
7.4. Vaginal Ring
8. Contraceptive Drug Eluting Devices Market, by Technology
8.1. Introduction
8.2. Biodegradable Polymer
8.2.1. PLA
8.2.2. PLGA
8.3. Non-Biodegradable Polymer
8.3.1. Ethylene Vinyl Acetate
8.3.2. Silicone
9. Contraceptive Drug Eluting Devices Market, by End User
9.1. Introduction
9.2. Clinics
9.2.1. Family Planning Centers
9.2.2. OB-GYN Clinics
9.3. Home Care
9.4. Hospitals
9.5. Specialty Centers
10. Contraceptive Drug Eluting Devices Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Contraceptive Drug Eluting Devices Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Contraceptive Drug Eluting Devices Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Contraceptive Drug Eluting Devices Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Actavis plc
15.2. Agile Therapeutics, Inc.
15.3. Allergan plc
15.4. Amgen Inc.
15.5. AstraZeneca PLC
15.6. Bayer AG
15.7. Bristol-Myers Squibb Company
15.8. Eli Lilly and Company
15.9. Evofem Biosciences, Inc.
15.10. GlaxoSmithKline plc
15.11. HRA Pharma
15.12. Johnson & Johnson
15.13. Merck & Co., Inc.
15.14. Mylan N.V.
15.15. Novartis AG
15.16. Novo Nordisk A/S
15.17. Pfizer Inc.
15.18. Roche Holding AG
15.19. Sanofi S.A.
15.20. Sun Pharmaceutical Industries Ltd.
15.21. Takeda Pharmaceutical Company Limited
15.22. Teva Pharmaceutical Industries Ltd.
15.23. Warner Chilcott plc
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Contraceptive Drug Eluting Devices Market, Years Considered for the Study
FIGURE 2. Global Contraceptive Drug Eluting Devices Market, Research Design
FIGURE 3. Global Contraceptive Drug Eluting Devices Market, Research Framework
FIGURE 4. Global Contraceptive Drug Eluting Devices Market, Data Triangulation
FIGURE 5. Global Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Contraceptive Drug Eluting Devices Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Contraceptive Drug Eluting Devices Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Contraceptive Drug Eluting Devices Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Contraceptive Drug Eluting Devices Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Contraceptive Drug Eluting Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Contraceptive Drug Eluting Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Contraceptive Drug Eluting Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Contraceptive Drug Eluting Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Contraceptive Drug Eluting Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Contraceptive Drug Eluting Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Contraceptive Drug Eluting Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Contraceptive Drug Eluting Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Contraceptive Drug Eluting Devices Market Segmentation & Coverage
TABLE 2. Global Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Implant Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Intrauterine System Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Intrauterine System Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Intrauterine System Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Vaginal Ring Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Vaginal Ring Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Vaginal Ring Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 14. Global Biodegradable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Biodegradable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Biodegradable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global PLA Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global PLA Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global PLA Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global PLGA Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global PLGA Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global PLGA Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Non-Biodegradable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Non-Biodegradable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Non-Biodegradable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Ethylene Vinyl Acetate Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Ethylene Vinyl Acetate Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Ethylene Vinyl Acetate Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Silicone Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Silicone Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Silicone Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 33. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Family Planning Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Family Planning Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Family Planning Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global OB-GYN Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global OB-GYN Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global OB-GYN Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Specialty Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Specialty Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Specialty Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 52. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 67. North America Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. North America Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 69. North America Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 70. North America Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 71. North America Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 72. North America Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. North America Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 74. North America Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 75. Latin America Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Latin America Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. Latin America Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 78. Latin America Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 79. Latin America Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 80. Latin America Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Latin America Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 82. Latin America Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 83. Europe Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Europe Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 85. Europe Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 86. Europe Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 87. Europe Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 88. Europe Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Europe Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 90. Europe Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. Middle East Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Middle East Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 93. Middle East Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 94. Middle East Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 95. Middle East Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 96. Middle East Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Middle East Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 98. Middle East Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. Africa Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Africa Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 101. Africa Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 102. Africa Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 103. Africa Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 104. Africa Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Africa Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 106. Africa Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. Global Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. ASEAN Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. ASEAN Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. ASEAN Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 111. ASEAN Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 112. ASEAN Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 113. ASEAN Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. ASEAN Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 115. ASEAN Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. GCC Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. GCC Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. GCC Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 119. GCC Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 120. GCC Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 121. GCC Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. GCC Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 123. GCC Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. European Union Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. European Union Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. European Union Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 127. European Union Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 128. European Union Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 129. European Union Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. European Union Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 131. European Union Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. BRICS Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. BRICS Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. BRICS Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 135. BRICS Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 136. BRICS Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 137. BRICS Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. BRICS Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 139. BRICS Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. G7 Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. G7 Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. G7 Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 143. G7 Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 144. G7 Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 145. G7 Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. G7 Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 147. G7 Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. NATO Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. NATO Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 150. NATO Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 151. NATO Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 152. NATO Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 153. NATO Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. NATO Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 155. NATO Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. Global Contraceptive Drug Eluting Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. United States Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 158. United States Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 159. United States Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 160. United States Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 161. United States Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 162. United States Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. United States Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 164. United States Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. Canada Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 166. Canada Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 167. Canada Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 168. Canada Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 169. Canada Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 170. Canada Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Canada Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 172. Canada Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. Mexico Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 174. Mexico Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. Mexico Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 176. Mexico Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 177. Mexico Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 178. Mexico Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Mexico Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 180. Mexico Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. Brazil Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 182. Brazil Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. Brazil Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. Brazil Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 185. Brazil Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 186. Brazil Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Brazil Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 188. Brazil Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. United Kingdom Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 190. United Kingdom Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. United Kingdom Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 192. United Kingdom Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 193. United Kingdom Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 194. United Kingdom Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. United Kingdom Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 196. United Kingdom Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. Germany Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 198. Germany Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. Germany Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 200. Germany Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 201. Germany Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 202. Germany Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Germany Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 204. Germany Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 205. France Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 206. France Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 207. France Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. France Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 209. France Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 210. France Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. France Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 212. France Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. Russia Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 214. Russia Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 215. Russia Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 216. Russia Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 217. Russia Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 218. Russia Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Russia Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 220. Russia Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. Italy Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 222. Italy Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 223. Italy Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. Italy Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 225. Italy Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 226. Italy Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Italy Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 228. Italy Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 229. Spain Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 230. Spain Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 231. Spain Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. Spain Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 233. Spain Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 234. Spain Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Spain Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 236. Spain Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. China Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 238. China Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. China Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 240. China Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 241. China Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 242. China Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. China Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 244. China Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. India Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 246. India Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 247. India Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 248. India Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 249. India Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 250. India Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. India Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 252. India Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Japan Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 254. Japan Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. Japan Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. Japan Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 257. Japan Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 258. Japan Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. Japan Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 260. Japan Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. Australia Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 262. Australia Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 263. Australia Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 264. Australia Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 265. Australia Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 266. Australia Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Australia Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 268. Australia Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 269. South Korea Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 270. South Korea Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. South Korea Contraceptive Drug Eluting Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 272. South Korea Contraceptive Drug Eluting Devices Market Size, by Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 273. South Korea Contraceptive Drug Eluting Devices Market Size, by Non-Biodegradable Polymer, 2017-2032 (USD Million)
TABLE 274. South Korea Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. South Korea Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 276. South Korea Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 277. Global Contraceptive Drug Eluting Devices Market Share, by Key Player, 2025
TABLE 278. Global Contraceptive Drug Eluting Devices Market, Key Experts

Companies Mentioned

  • Actavis plc
  • Agile Therapeutics, Inc.
  • Allergan plc
  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Evofem Biosciences, Inc.
  • GlaxoSmithKline plc
  • HRA Pharma
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Warner Chilcott plc

Related Topics

Related Reports

Implantable Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032 - Product Image

Implantable Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Drug Eluting Implants Market - Forecasts from 2025 to 2030 - Product Image

Drug Eluting Implants Market - Forecasts from 2025 to 2030

  • Report
  • 148 Pages
  • Global
From
Intra-Uterine Contraceptive Devices Market Report 2026 - Product Image

Intra-Uterine Contraceptive Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Drug Eluting Stent Market - Global Forecast 2026-2032 - Product Image

Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Female Contraceptives - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Female Contraceptives - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 112 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.